DIN 02354225 — INVEGA SUSTENNA 75 MG
INVEGA SUSTENNA is a suspension (extended-release) of Paliperidone Palmitate marketed by JANSSEN INC. The full Paliperidone Palmitate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02354225
- Brand name
- INVEGA SUSTENNA
- Active ingredient
- Paliperidone Palmitate
- Strength
- 75 MG
- Dosage form
- SUSPENSION (EXTENDED-RELEASE)
- Route
- INTRAMUSCULAR
- Manufacturer
- JANSSEN INC
- Health Canada status
- MARKETED
- Drug class
- Atypical (second-generation) antipsychotic
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Paliperidone Palmitate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02354233 | INVEGA SUSTENNA | 100 MG | SUSPENSION (EXTENDED-RELEASE) | JANSSEN INC | MARKETED |
| 02354241 | INVEGA SUSTENNA | 150 MG | SUSPENSION (EXTENDED-RELEASE) | JANSSEN INC | MARKETED |
| 02354217 | INVEGA SUSTENNA | 50 MG | SUSPENSION (EXTENDED-RELEASE) | JANSSEN INC | MARKETED |
| 02455943 | INVEGA TRINZA | 175 MG | SUSPENSION (EXTENDED-RELEASE) | JANSSEN INC | MARKETED |
| 02455986 | INVEGA TRINZA | 263 MG | SUSPENSION (EXTENDED-RELEASE) | JANSSEN INC | MARKETED |
| 02455994 | INVEGA TRINZA | 350 MG | SUSPENSION (EXTENDED-RELEASE) | JANSSEN INC | MARKETED |
| 02456001 | INVEGA TRINZA | 525 MG | SUSPENSION (EXTENDED-RELEASE) | JANSSEN INC | MARKETED |